Pharma Intermediates Powder Anti Inflammatory Palmitoylethanolamide/Micro CAS 544-31-0

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Palmitoylethanolamide
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >98%
• Product Name: Palmitoylethanolamide
• CAS No.: 544-31-0
• Molecular Formula: C18h37no2
• Molecular Weight: 299.49
• Melting Point: 97-98ºC
• Boiling Point: 461.5±28.0 °c(Predicted)
• Density: 0.910±0.06 g/cm3(Predicted)
• Transport Package: Foil Bag
• Specification: 1kg /bag
• Trademark: SENWAYER
• Origin: China
• HS Code: 2924199090
• Production Capacity: 1000kg/Month

Product Description

 Pharma Intermediates Powder Anti Inflammatory Palmitoylethanolamide/Micro CAS 544-31-0

Product name	Palmitoylethanolamide
CAS number	544-31-0
Molecular formula	C18H37NO2
Molecular weight	299.49

Appearance	White powder
Purity	99.0%
Function	Main FunctionPalmitoylethanolamide Anti-Inflammatory and AnalgesicPalmitoylethanolamide Improve the ability ofimmunityPalmitoylethanolamide Treate chronic painPalmitoylethanolamide Treate epilepsy, cerebral ischemia and strokePalmitoylethanolamide Treate Alzheimer's disease and Parkinson's disease PEA has been explored in humans; spanning various clinical trials in a variety of pain states, for inflammatory and pain syndromes. Its positive influence in atopic eczema for instance seems to originate from PPAR alpha activation. PEA is available for human use as a dietary supplement.   In a 2012 review, all clinical trials to date were summarized. In a 2015 analysis of a double blind placebo controlled study of PEA in sciatic pain, the Numbers Needed to Treat was 1.5. Its positive influence in chronic pain, and inflammatory states such as atopic eczema, seems to originate mainly from PPAR alpha activation. Since 2012 a number of new trials have been published, among which studies in glaucoma. PEA also seems to be one of the factors responsible for the decrease in pain sensitivity during and after sport, comparable to the endogenous opiates (endorphines).
Discribe	Palmitoylethanolamide(pea) Powder is an endogenous fatty acid amide, belonging to the class of nuclear factor agonists. PEA has been demonstrated to bind to a receptor in the cell-nucleus (a nuclear receptor) and exerts a great variety of biological functions related to chronic pain and inflammation. The main target is thought to be the peroxisome proliferator-activated receptor alpha (PPAR-α). It is an endogenous fattyacid amide, belonging to the class of nuclear factor agonists. PEA is one of themost important endogenous painkilling and anti-inflammatory compounds and has been shown to effective for both acute and chronic pain. Because the substanceacts as a natural painkiller, it is an excellent alternative for conventionalmedications that might cause side effects.

Palmitoylethanolamide is a natural substance identical to the body's own.
Palmitoylethanolamide in scientific literature, PEA is described as a very promising substance for various disorders that are accompanied by inflammations and infections.
Palmitoylethanolamide (N-palmitoylethanolamine) can be found in food, such as meat, eggs, soybeans and peanuts.
Palmitoylethanolamide can be used in combination with medication, antibiotics, anti-fever and anti-coughing medication,analgesics and/or anti-inflammatory agents.
Palmitoylethanolamide,there are no known problematic side-effects of PEA.
Palmitoylethanolamide,there are two forms: Palmitoylethanolamide powder and Ultra-micronized palmitoylethanolamide powder, the micronized palmitoylethanolamide is much easier to absorb than common one. As one dietary supplement sold on the market,palmitoylethanolamide supplement is usually made into capsule and softgel form.